News

Filter

Current filters:

Anti-virals

176 to 185 of 97182 results

Lilly in-licenses Zosano’s osteo patch for up to $440 million

03-12-2014

Privately-held US biotech firm Zosano Pharma has entered into an exclusive agreement with pharma major…

Anti-Arthritics/RheumaticsBiotechnologyEli LillyLicensingZosano PharmaZP-PTH

Evotec and Sanofi negotiate 250 million euro strategic collaboration

Evotec and Sanofi negotiate 250 million euro strategic collaboration

03-12-2014

German biotech company Evotec has entered into exclusive negotiations with French drug major Sanofi on…

EvotecFranceGermanyPharmaceuticalResearchSanofi

Puma shares plummet as it delays NDA filing

Puma shares plummet as it delays NDA filing

03-12-2014

Puma Biotechnology will delay the filing of its New Drug Application (NDA) for the approval of PB272…

BiotechnologyneratinibOncologyPuma BiotechnologyRegulationUSA

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

FDA approves Sanofi’s Priftin for latent TB

FDA approves Sanofi’s Priftin for latent TB

03-12-2014

French pharma major Sanofi says that the US Food and Drug Administration has approved Priftin (rifapentine),…

Antibiotics and Infectious diseasesPharmaceuticalPriftinRegulationSanofiUSA

Russia may face a shortage of drugs against HIV

Russia may face a shortage of drugs against HIV

02-12-2014

Russia may face a shortage of drugs against HIV, due to disruptions of state auctions for the public…

Anti-viralsHealthPharmaceuticalProductionRussia

Merck Ebola vaccine is well-tolerated by volunteers in early trials

Merck Ebola vaccine is well-tolerated by volunteers in early trials

02-12-2014

The Ebola vaccine developed by pharma giant Merck & Co and NewLink has been well-tolerated by trial volunteers…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearch

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

02-12-2014

The global chronic obstructive pulmonary disease and asthma devices market is expected to reach $34 billion…

Dosage formsMarkets & MarketingMedicinePharmaceuticalRespiratory and Pulmonary

Russia faces steady growth of drug prices

Russia faces steady growth of drug prices

02-12-2014

Drug prices in Russia are steadily growing, due to the deterioration of the local business environment…

PharmaceuticalPharmaceuticals policyPharmacologyPricingRussia

176 to 185 of 97182 results

Back to top